New research suggests that monitoring sleep quality could help healthcare providers identify respiratory issues before they become advanced.
RT’s Three Key Takeaways:
- Respiratory Decline Link: Researchers found that forced vital capacity is a significant predictor of sleep efficiency, indicating that breathing impairment often emerges first during sleep.
- Early Symptom Identification: Subtle signs such as morning headaches, unrefreshing sleep, and fragmented sleep may signal respiratory insufficiency before the onset of more severe symptoms.
- Clinical Intervention: The findings support earlier use of polysomnography to identify hypoventilation and guide the timely initiation of noninvasive ventilation for patients.
Significant sleep disruption is common in people with amyotrophic lateral sclerosis (ALS), and these changes may serve as an early warning sign of declining respiratory function, according to a study published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
The retrospective cohort study analyzed 240 people with ALS who underwent polysomnography, a type of sleep study, after their diagnosis. The participants had a median age of 59.3 years at symptom onset, and 63% were male. Most of the group represented advanced cases of the disease, with 83% classified as King stage 4 at the time of the sleep study.
The researchers found that respiratory dysfunction was prevalent among the participants. The median forced vital capacity (FVC) was reduced to 58%, and FVC levels declined by a median of 3.9 percentage points per month in the period leading up to the polysomnography. Sleep quality was also markedly impaired, with a median total sleep time of 339 minutes and a sleep efficiency of 62.8%.
FVC emerged as a significant predictor of sleep efficiency after the researchers adjusted for age and sex. Patients with an FVC of 70% or lower had significantly higher rates of wakefulness after sleep onset. The study also observed trends toward lower sleep efficiency and less rapid eye movement sleep in these patients.
The findings reinforce the clinical importance of monitoring sleep disturbances in ALS patients, particularly because respiratory symptoms can be subtle before respiratory insufficiency becomes advanced. Symptoms such as morning headaches, unrefreshing sleep, daytime sleepiness, and fragmented sleep may provide earlier clues for healthcare providers than traditional signs like dyspnea or orthopnea.
The site of disease onset also appeared to influence sleep patterns. People with spinal onset ALS had a significantly higher number of arousals during the night than those with bulbar onset disease. The authors suggested that a reduced ability to reposition during sleep, muscle cramps, general discomfort, or a higher incidence of sleep apnea may contribute to this difference.
Survival analyses conducted during the study showed that spinal onset, a slower decline in FVC before the sleep study, and a preserved FVC of at least 70% at the time of the study were associated with improved survival. Preserved sleep efficiency also showed a trend toward better survival outcomes.
The results support continued vigilance for nocturnal respiratory dysfunction, as breathing impairment often manifests during sleep before it is detectable during waking hours. The authors noted that earlier referral for polysomnography may help identify hypoventilation and guide the timely consideration of noninvasive ventilation (NIV), though the optimal timing for starting NIV remains a subject of debate in the medical community.
Reference
Bracaval K et al. Sleep disturbances and respiratory dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2026;1-7.
This article was originally published by AMJ and was made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
